Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Options trading offers unique opportunities to boost investment returns. Discover how to leverage options for greater gains.
25,570 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Gold has surged roughly 50% in the past year, but most portfolios remain lightly exposed. State Street’s 2026 outlook...
Star Bulk reported a solid Q1 2026, reflecting steady demand for commodities and a modern fleet. This article unpacks...
Alphabet and Meta are steering through a redefining ad market shaped by AI investment. This piece compares valuation,...
The S&P 500 has climbed about 9% in 2026 amid mixed signals. This guide breaks down what Wall Street expects next, pl...
Investors eye the physical ai’s trillion opportunity—a potential $50 trillion payoff from industrial AI—but it requir...
Wall Street watches a hypothetical shift as chair kevin warsh just signals a new, discipline-focused approach at the ...
Nike faces a pivotal few years as it shifts toward direct-to-consumer and digital growth. This deep dive outlines whe...
Looking for steady income in a volatile market? This guide highlights three high-yield energy stocks march investors ...
XRP sits in a tight range around $1.40 as analysts map the path to a potential break all-time high this year. The out...
Retirees facing rising taxes must plan withdrawals carefully. With $2M in retirement accounts, a strategic advisor ca...
Bridgewater Associates exits its Salesforce stake, prompting a broader discussion on how patient capital should value...